LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Medtronic PLC

Затворен

СекторЗдравеопазване

94.03 1.24

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

92.93

Максимум

94.27

Ключови измерители

By Trading Economics

Приходи

-17M

1B

Продажби

-349M

8.6B

P/E

Средно за сектора

25.638

35.733

EPS

1.26

Дивидентна доходност

3.06

Марж на печалбата

12.124

Служители

95,000

EBITDA

-50M

2.2B

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+7.42% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.06%

3.13%

Следващи печалби

18.11.2025 г.

Следваща дата на дивидент

17.10.2025 г.

Следваща дата на екс-дивидент

26.09.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

133M

119B

Предишно отваряне

92.79

Предишно затваряне

94.03

Настроения в новините

By Acuity

26%

74%

82 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Medtronic PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.08.2025 г., 11:39 ч. UTC

Печалби

Medtronic Posts Higher 1Q Revenue, Boosts Outlook as Tariffs Ease

21.05.2025 г., 11:38 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Medtronic Boosts Dividend, Plans to Separate Diabetes Business and Targets Revenue Growth for Year

19.08.2025 г., 20:33 ч. UTC

Печалби
Придобивния, сливания и поглъщания

These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More -- Barrons.com

19.08.2025 г., 17:41 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19.08.2025 г., 13:35 ч. UTC

Горещи акции

Stocks to Watch Tuesday: Intel, Medtronic, Home Depot -- WSJ

19.08.2025 г., 12:48 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19.08.2025 г., 11:27 ч. UTC

Печалби

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19.08.2025 г., 10:51 ч. UTC

Печалби

Medtronic Sees FY26 Reported Revenue Growth 6.5%-6.8% >MDT

19.08.2025 г., 10:50 ч. UTC

Печалби

Medtronic Had Seen FY26 Adjusted EPS $5.50-$5.60 >MDT

19.08.2025 г., 10:50 ч. UTC

Печалби

Medtronic Raises FY26 View To Adj EPS $5.60-Adj EPS $5.66 >MDT

19.08.2025 г., 10:50 ч. UTC

Печалби

Medtronic Cuts FY26 Potential Tariff Impact View to About $185M From $200M-$350M >MDT

19.08.2025 г., 10:49 ч. UTC

Печалби

Medtronic Raises FY26 Adjusted EPS Growth View to About 4.5% From About 4%, Excluding Potential Tariff Impact >MDT

19.08.2025 г., 10:48 ч. UTC

Печалби

Medtronic Still Sees FY26 Organic Revenue Up About 5% >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Medical Surgical Portfolio Rev $2.08B >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Cardiovascular Portfolio Rev $3.29B >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Neuroscience Portfolio Rev $2.42B >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Organic Revenue Up 4.8% >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q EPS 81c >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Net $1.04B >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Diabetes Rev $721M >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Sales $8.58B >MDT

19.08.2025 г., 10:45 ч. UTC

Печалби

Medtronic 1Q Adj EPS $1.26 >MDT

19.08.2025 г., 09:12 ч. UTC

Горещи акции

Stocks to Watch Tuesday: Intel, Palo Alto, Tegna, Home Depot -- WSJ

12.06.2025 г., 13:01 ч. UTC

Придобивния, сливания и поглъщания

Medtronic Targeting Completion of Planned Separation Within 18 Mos of Initial Announcement >MDT

21.05.2025 г., 17:23 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Medtronic to Separate Diabetes Business as Stand-Alone Company -- 2nd Update

21.05.2025 г., 11:39 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Medtronic to Separate Diabetes Business as Stand-Alone Company -- Update

21.05.2025 г., 10:52 ч. UTC

Печалби

Medtronic Sees FY26 Adjusted EPS Up About 4% Excluding Potential Impacts From Increased Tariffs >MDT

21.05.2025 г., 10:51 ч. UTC

Печалби

Medtronic Sees FY26 Adj EPS $5.50-Adj EPS $5.60, Including Potential Tariff Impact >MDT

21.05.2025 г., 10:50 ч. UTC

Печалби

Medtronic Sees FY26 Reported Revenue Up 4.8%-5.1% if Recent Forex Rates Hold >MDT

21.05.2025 г., 10:49 ч. UTC

Печалби

Medtronic Sees FY26 Organic Revenue Growth Up About 5% >MDT

Сравнение с други в отрасъла

Ценова промяна

Medtronic PLC Прогноза

Ценова цел

By TipRanks

7.42% нагоре

12-месечна прогноза

Среден 99.89 USD  7.42%

Висок 115 USD

Нисък 78 USD

Според 26 анализатори от Wall Street, предложили 12-месечна ценова цел за Medtronic PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

26 ratings

13

Купи

12

Задържане

1

Продай

Техническа оценка

By Trading Central

83.26 / 84.875Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

82 / 371 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat